Retatrutide is currently in Phase 3 trials. MHRA approval expected 2026–2027 at earliest. Here’s what the clinical trial timeline looks like — and how you can get retatrutide in the UK today.
Retatrutide is currently in Phase 3 trials. MHRA approval expected 2026–2027 at earliest. Here’s what the clinical trial timeline looks like — and how you can get retatrutide in the UK today.
Deutsch 
English 
Español 
Español de México 
English (Australia) 
Français du Canada